Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,693-16,704 of 23,847
Drug study icon
CompletedNCT02989727

Melancholic Symptoms in Depression in bipolarity and Responsiveness to Lamotrigine

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

In Saskatoon
Bipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
Canada
Sponsor
University of Saskatchewan
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT03826563

Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

In Philadelphia
SchizophreniaDrugFrom 11 Years to 30 Years
Countries
United States
Sponsor
Children's Hospital of Philadelphia
Condition
Schizophrenia
Drug study icon
CompletedEUCTR ISRCTN28988273

Melatonin in Acute Mania Investigation (MIAMI-UK)

This study is looking at whether Melatonin (circadin) 2 mg tablet orally at night 1 hour 30 min before sleep, or placebo for 21 days can help people with bipolarity, Mental and Behavioural Disorders, or Bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
BipolarityOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Bipolarity
Drug study icon
CompletedNCT00512070

Melatonin Metabolism Abnormality in people with Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

In Tacoma
Schizophrenia, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Seattle Institute for Biomedical and Clinical Research
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.